Sales going no where fast. Problem here is until TAVR gets into human trials or completes them I can’t see anyone wanting to partner. If that’s the case we have years of “ non dilutive funding” ahead of us, or if that’s not possible dilutive funding. IMO
Ann: Appendix 4C - quarterly, page-9
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.12 |
Change
-0.180(1.18%) |
Mkt cap ! $319.6M | |||
| Open | High | Low | Value | Volume |
| $15.11 | $15.16 | $15.11 | $26.66K | 1.764K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 178 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 36 | 1 |
View Market Depth
| Last trade - 11.07am 01/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |